For professionals in the pharmaceutical industry, securing a reliable source of high-quality Rasagiline Mesylate is paramount for the successful development and production of Parkinson's disease treatments. As a key MAO-B inhibitor, Rasagiline Mesylate plays a critical role in managing the motor symptoms associated with this neurodegenerative disorder by increasing dopamine levels in the brain.

When evaluating suppliers, procurement managers should prioritize manufacturers that offer a consistent purity of over 99%, verified through rigorous testing methods like HPLC, UV, and TLC. This ensures that the active pharmaceutical ingredient (API) will perform effectively in its intended application. Understanding the product's physical characteristics, such as its white powder appearance and recommended storage conditions (cool, dry, sealed container, below 5ºC), is also vital for maintaining product integrity from purchase to formulation.

The CAS number 161735-79-1 is the identifier for Rasagiline Mesylate, and a reputable manufacturer will readily provide detailed documentation, including Certificates of Analysis (COA), to confirm product specifications. Companies looking to buy Rasagiline Mesylate in bulk will benefit from understanding the supplier's production capacity and lead times. A production capacity of 5000kg/month, coupled with fast delivery options of 7-10 days, indicates a robust supply chain capable of meeting substantial demand.

When inquiring about pricing, it's important to consider not only the per-unit cost but also the total value offered, including quality assurance, reliable delivery, and potential for long-term partnership. Engaging with suppliers who are experienced in pharmaceutical intermediates and hold certifications such as GMP and ISO signifies a commitment to quality and regulatory compliance. By focusing on these key aspects, pharmaceutical procurement teams can ensure they are partnering with a trustworthy manufacturer and supplier for their Rasagiline Mesylate needs.